Medistim ASA (STO:MEDIO)
Sweden · Delayed Price · Currency is SEK · Price in NOK 220.00
0.00 (0.00%)
At close: Mar 3, 2026
Revenue by Geography
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Americas Revenue | 276.34M | 322.32M | 237.16M | ||||||||||||
Americas Revenue Growth | -14.27% | 35.91% | 13.46% | ||||||||||||
APAC Revenue | 80.93M | 92.18M | 65.28M | ||||||||||||
APAC Revenue Growth | -12.20% | 41.20% | -21.33% | ||||||||||||
EMEA Revenue | 177.39M | 184.03M | 170.34M | ||||||||||||
EMEA Revenue Growth | -3.60% | 8.04% | 9.94% | ||||||||||||
Third Party Products Revenue | 99.85M | 101.24M | 89.82M | ||||||||||||
Third Party Products Revenue Growth | -1.38% | 12.72% | 13.08% |
Revenue Breakdown
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
PPP and Lease Revenue - Flow Procedures (PPP/Card Based) | 54.84M | 62.27M | 61.34M | ||||||||||||
PPP and Lease Revenue - Flow Procedures (PPP/Card Based) Growth | -11.94% | 1.52% | -4.71% | ||||||||||||
PPP and Lease Revenue - Imaging and Flow Procedures (PPP/Card Based) | 40.71M | 40.73M | 39.50M | ||||||||||||
PPP and Lease Revenue - Imaging and Flow Procedures (PPP/Card Based) Growth | -0.04% | 3.10% | 9.00% | ||||||||||||
Capital Sales - Flow Systems | 62.76M | 59.95M | 55.22M | ||||||||||||
Capital Sales - Flow Systems Growth | 4.70% | 8.56% | -0.59% | ||||||||||||
Capital Sales - Flow and Imaging Systems | 99.27M | 119.13M | 69.17M | ||||||||||||
Capital Sales - Flow and Imaging Systems Growth | -16.67% | 72.22% | -15.11% | ||||||||||||
Capital Sales - Flow Probes | 257.93M | 292.41M | 231.47M | ||||||||||||
Capital Sales - Flow Probes Growth | -11.79% | 26.33% | 19.89% | ||||||||||||
Capital Sales - Imaging Probes | 19.17M | 240.54M | 16.08M | ||||||||||||
Capital Sales - Imaging Probes Growth | -92.03% | 1395.62% | -0.92% | ||||||||||||
Total Own Products Revenue | 534.67M | 598.53M | 472.78M | ||||||||||||
Total Own Products Revenue Growth | -10.67% | 26.60% | 5.78% | ||||||||||||
Third Party Products Revenue | 99.85M | 101.24M | 89.82M | ||||||||||||
Third Party Products Revenue Growth | -1.38% | 12.72% | 13.08% |
Revenue Breakdown 2
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Third Party Products Revenue | 99.85M | 101.24M | 89.82M | ||||||||||||
Third Party Products Revenue Growth | -1.38% | 12.72% | 13.08% | ||||||||||||
Coronary Surgery Revenue | 421.36M | 476.26M | 379.05M | ||||||||||||
Coronary Surgery Revenue Growth | -11.53% | 25.64% | 3.67% | ||||||||||||
Vascular Surgery Revenue | 113.31M | 122.26M | 93.72M | ||||||||||||
Vascular Surgery Revenue Growth | -7.32% | 30.45% | 15.29% |
Revenue by Geography 3
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Third Party Products Revenue | 99.85M | 101.24M | 89.82M | ||||||||||||
Third Party Products Revenue Growth | -1.38% | 12.72% | 13.08% |
Key Performance Indicators
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
PPP and Lease Revenue - Flow Procedures (PPP/Card Based) Units Sold | 21.94K | 26.19K | 23.54K | ||||||||||||
PPP and Lease Revenue - Flow Procedures (PPP/Card Based) Units Sold Growth | -16.23% | 11.29% | -9.68% | ||||||||||||
PPP and Lease Revenue - Imaging and Flow Procedures (PPP/Card Based) Units Sold | 8.12K | 9.28K | 7.48K | ||||||||||||
PPP and Lease Revenue - Imaging and Flow Procedures (PPP/Card Based) Units Sold Growth | -12.50% | 24.12% | -7.05% | ||||||||||||
PPP and Lease Revenue - Flow Systems (PPP/Lease) Units Sold | - | - | 4.00 | ||||||||||||
PPP and Lease Revenue - Flow and Imaging Systems (PPP/Lease) Units Sold | 3.00 | 2.00 | 5.00 | ||||||||||||
PPP and Lease Revenue - Flow and Imaging Systems (PPP/Lease) Units Sold Growth | 50.00% | -60.00% | 25.00% | ||||||||||||
Capital Sales - Flow Systems Units Sold | 129.00 | 121.00 | 116.00 | ||||||||||||
Capital Sales - Flow Systems Units Sold Growth | 6.61% | 4.31% | -19.44% | ||||||||||||
Capital Sales - Flow and Imaging Systems Units Sold | 78.00 | 92.00 | 66.00 | ||||||||||||
Capital Sales - Flow and Imaging Systems Units Sold Growth | -15.22% | 39.39% | -29.03% | ||||||||||||
Capital Sales - Flow Probes Units Sold | 10.46K | 11.62K | 9.63K | ||||||||||||
Capital Sales - Flow Probes Units Sold Growth | -10.06% | 20.72% | 5.63% | ||||||||||||
Capital Sales - Imaging Probes Units Sold | 152.00 | 164.00 | 132.00 | ||||||||||||
Capital Sales - Imaging Probes Units Sold Growth | -7.32% | 24.24% | -21.43% |
Updated Jun 30, 2025. Data Source: Fiscal.ai.